Starfish medical icon only logo
Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Why Microneedles Still Matter in Drug Delivery

YouTube video thumbnail

In this episode of Bio Break, Nigel and Nick explore microneedle drug delivery—a growing field in medtech that aims to improve patient comfort and treatment compliance. While the term “microneedles” may sound futuristic, this technology has been around for years. The goal? Deliver medicine through the skin with less pain, less fear, and fewer barriers to care.

What Is Microneedle Drug Delivery?

Microneedles are tiny structures, often as small as a human hair, that can puncture the skin’s outer layer to administer medication. Some dissolve into the skin, while others act as miniature hollow syringes. Unlike traditional injections, microneedle drug delivery can avoid deeper nerve endings—meaning less pain for the patient.

Advantages Over Traditional Injections

The key benefit of microneedles is improved patient compliance. Many people skip essential treatments due to needle anxiety. By minimizing discomfort, microneedles make it easier for patients to stick with treatment plans. This approach could be especially useful for vaccines, hormone therapies, or chronic care where regular administration is needed.

Limitations and Drug Compatibility

Not all medications are suitable for microneedle delivery. Larger molecules may not pass through the tiny channels or could be damaged by shear forces. Product developers must consider drug formulation, molecule size, and delivery speed when selecting this method.

Future Outlook and Applications

Microneedle drug delivery has potential in both consumer health and clinical use, but widespread adoption depends on finding scalable applications. The technology continues to evolve, particularly in pairing with biologics and nanoparticles.

Learn more about StarFish Medical.

Businessman holding a glowing compliance icon with legal and regulatory symbols, representing REACH SVHC compliance for medical device manufacturers

MPO: REACH SVHC Compliance for Medical Device Makers

Nigel Syrotuck breaks down REACH SVHC compliance for teams working with material suppliers and compliance questionnaires.

Medical Device Design Simulation

MD+DI: Medical Device Simulation Strategy That Works

We examine when computational modelling and simulation, or CM&S, genuinely supports medical device simulation strategy and when it becomes a costly detour.

Transparent medical device prototype surrounded by computational simulation mesh representing modeling and simulation during medical device development.

Building Better Medical Devices Faster: The Strategic Role of CM&S

Many teams still underuse CM&S, often bringing it late in device validation, when key decisions have already been made. That approach leaves much of the value of CM&S untapped.

Biomedical engineer reviewing a thermal simulation of human head tissue on a monitor, color-mapped from warm to cool gradients

Bioheat Transfer in Living Tissue: History, Models, and Engineering Applications

This article traces the Pennes bioheat equation from its 1948 origins to modern multiscale approaches, explaining how engineers select the right level of modelling complexity across device categories.